Restless legs syndrome (RLS) is a neurological condition driven primarily by disrupted dopamine signaling and, in many cases, low iron levels in the brain. It affects roughly five to ten percent of the general population and produces an uncomfortable urge to move the legs that strikes during rest, worsens at night, and eases with movement. Despite how common it is, RLS was largely dismissed as a quirky complaint until surprisingly recently, and it remains underdiagnosed today, particularly in children and people with conditions that mask it.
How RLS Is Recognized
A diagnosis rests on four clinical criteria established by a National Institutes of Health consensus panel: you feel an urge to move your legs, usually accompanied by unpleasant sensations; the urge begins or worsens during periods of rest or inactivity; movement partially or completely relieves it; and symptoms are worse in the evening or at night, or only occur during those hours.1PubMed Central. Restless legs syndrome: differential diagnosis and management with pramipexole All four must be present. No blood test or brain scan confirms RLS on its own. The diagnosis is entirely based on what you describe to a clinician.
The sensations people report vary widely. Some describe a crawling feeling deep inside the calves; others call it a pulling, throbbing, or aching. A few say it feels like insects moving under the skin. The common thread is that lying still becomes intolerable. You feel compelled to get up, walk around, or at least flex your legs, and the moment you do, the discomfort fades. Then you sit or lie down again, and it comes back.
One pitfall in diagnosis is that these four criteria can overlap with other conditions. Painful diabetic neuropathy, for instance, also causes leg discomfort that worsens at rest, and people with diabetes develop RLS at higher-than-average rates, making it tricky to sort out which condition is responsible for which symptoms.2PubMed Central. Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes Leg cramps, positional discomfort, and arthritis pain can also mimic the pattern.3PubMed Central. The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions (“mimics”) The circadian element, that symptoms reliably peak in the evening and at night, is often the detail that separates genuine RLS from look-alikes.
The Iron-Dopamine Connection
Two biological threads run through almost all RLS research: dopamine signaling in the brain is disrupted, and brain iron levels are often low, even when standard blood tests come back normal. These two problems are connected, because iron is a required cofactor for the enzyme that produces dopamine. When the brain does not have enough iron, dopamine production and regulation suffer.
Imaging and cerebrospinal fluid studies consistently show that people with RLS have reduced iron and ferritin in the brain, particularly in the substantia nigra, a region central to dopamine activity.4PubMed. CSF iron, ferritin and transferrin levels in restless legs syndrome This brain iron deficit can exist independently of what is happening in the rest of the body; your blood iron panel may look perfectly fine while the transport mechanisms that move iron across the blood-brain barrier are not working efficiently.5PubMed Central. Restless Legs and Iron Deficiency: Unraveling the Hidden Link and Unlocking Relief Newer research has found that neurons in people with RLS may actually shed iron-loaded particles, further depleting their own intracellular iron stores.6PubMed Central. Brain Iron Dysregulation in Iron Deficiency Anemia-Related Restless Leg Syndrome Revealed by Neuron-Derived Extracellular Vesicles: A Case-Control Study
On the dopamine side, brain-imaging meta-analyses show decreased functional connectivity in the dopaminergic pathways of people with RLS, including the circuits responsible for movement planning and sensory processing.7PubMed Central. Differential functional connectivity in thalamic and dopaminergic pathways in restless legs syndrome: a meta-analysis Studies of immune cells in RLS patients have found lower expression of D2 dopamine receptors, suggesting the underactivity extends beyond the brain.8PubMed Central. Peripheral Dopamine in Restless Legs Syndrome The picture that emerges is not simply “too little dopamine” but rather a system whose dopamine regulation is off-kilter, which is an important distinction when it comes to treatment.
Why Symptoms Peak at Night
One of the defining and most frustrating features of RLS is its circadian rhythm. You might feel perfectly fine all morning and afternoon, then start noticing symptoms as evening sets in. Research has explored several biological clocks that could drive this pattern, including daily fluctuations in iron availability, dopamine levels, core body temperature, and hormones like melatonin and thyroid-stimulating hormone.9PubMed Central. Circadian rhythm in restless legs syndrome
Among these, melatonin stands out. In a study that tracked RLS patients around the clock, the rise in melatonin secretion in the evening consistently preceded the worsening of leg discomfort and involuntary limb movements. Melatonin appears to inhibit central dopamine release, which could explain why symptoms hit hardest right when your body is preparing for sleep.10PubMed. Circadian rhythm of restless legs syndrome: relationship with biological markers This timing is what makes RLS such a potent sleep disruptor. The symptoms arrive precisely when you need to be still and relaxed.
Genetics and Family History
RLS runs in families. Early genetic studies identified a handful of chromosomal regions linked to the condition and pointed to an autosomal dominant inheritance pattern in some families, meaning a single copy of the risk variant from one parent could be enough to produce symptoms.11PubMed Central. Genetic aspects of restless legs syndrome The strongest single genetic risk factor identified so far is a region near a gene called MEIS1 on chromosome 2.12The Lancet Neurology. Meta-analysis of genome-wide association studies identifies 13 new risk loci for restless legs syndrome
But the genetic landscape is far more complex than a single gene. A large genome-wide meta-analysis published in 2024 expanded the number of known risk loci eightfold to 164, including three on the X chromosome.13Nature Genetics. Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology and risk prediction That many loci spread across the genome suggest RLS is not a single-gene disorder but a condition shaped by many small genetic contributions, each nudging the risk up a bit. This fits the clinical picture well: some people have severe symptoms from adolescence, while others develop mild symptoms in middle age that slowly progress.
Secondary Causes and Triggers
Not all RLS is inherited. A range of medical conditions and medications can trigger or worsen it.
Kidney disease is one of the most well-established triggers. Among people on dialysis, the prevalence of RLS is roughly two to three times higher than in the general population, with most studies reporting rates between 15 and 30 percent.14PubMed Central. Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review The proposed mechanism involves a combination of iron imbalance in the central nervous system, chronic inflammation, oxidative stress, and elevated phosphorus levels.15PubMed Central. Dialysis Patients With Restless Leg Syndrome: Can We Relieve Their Suffering?
Pregnancy is another common trigger. Symptoms tend to peak in the third trimester and usually resolve around delivery.16PubMed. Pregnancy as a risk factor for restless legs syndrome In a prospective study that tracked pregnant women, more than half reported RLS onset before the 20th week, and both symptom severity and involuntary limb movements dropped by more than half after delivery.17PubMed. Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study The likely culprits are the shifting iron demands of pregnancy and hormonal changes that affect dopamine.
Certain medications can also provoke or worsen RLS. Antidepressants are the most frequently discussed class. A systematic review found that while the overall rate of antidepressant-triggered RLS is uncommon, specific drugs, particularly mirtazapine and venlafaxine, were associated with higher rates of new or worsened symptoms.18PubMed. The influence of antidepressants on restless legs syndrome and periodic limb movements: A systematic review An analysis of two decades of FDA adverse-event reports confirmed that a wide range of medications can trigger RLS onset or make existing symptoms worse.19PubMed Central. Exploring the Top 50 Drugs Associated with Restless Legs Syndrome Based on the FDA Data from 2004 to 2024 If your symptoms appeared or escalated shortly after starting a new medication, that timing is worth mentioning to your doctor.
What RLS Does to Sleep and Overall Health
The most immediate consequence of RLS is disrupted sleep. Many people with RLS also experience periodic limb movements during sleep, which are repetitive, involuntary jerking or twitching motions of the legs that can fragment sleep without you fully waking up. These movements are not the same as RLS itself; periodic limb movements occur in other sleep disorders and even in healthy people, so they are not diagnostic on their own.20PubMed. The restless legs syndrome and periodic limb movement disorder: a review of management But when they coexist with RLS, the combination can devastate sleep quality.
Beyond poor sleep, mounting evidence ties RLS to cardiovascular risk. A study of middle-aged women found that those with frequent RLS symptoms (more than 15 episodes per month) had roughly 40 percent higher odds of hypertension compared to women without RLS, even after adjusting for other risk factors. Both systolic and diastolic blood pressure climbed in a dose-response pattern as symptom frequency increased.21PubMed Central. Restless Legs Syndrome and Hypertension in Middle-Age Women Separate research has found that RLS patients show abnormal 24-hour blood pressure patterns, including a reduced nighttime dip that is itself an independent cardiovascular risk factor.22Scientific Reports. Blood pressure profile and endothelial function in restless legs syndrome A 2025 review in JAMA reported that about 30 percent of people with RLS have coronary artery disease, stroke, or heart failure.23JAMA. Restless Legs Syndrome: A Review Whether RLS directly causes cardiovascular disease or simply shares risk factors with it is still debated, but the association is strong enough to warrant attention.
Mental Health and Quality of Life
RLS takes a toll that goes beyond physical discomfort and bad sleep. Depression rates among people with RLS hover around 30 percent, and observational studies support a bidirectional relationship: depression can worsen RLS, and RLS can worsen depression.23JAMA. Restless Legs Syndrome: A Review Anxiety is common as well. Perhaps more alarming, suicidal ideation appears at elevated rates in RLS patients, and recent work suggests this can persist even when depressive symptoms improve, meaning it may not be purely a secondary effect of feeling down.24Current Treatment Options in Neurology. Restless Legs Syndrome and Mental Health Disturbances: Clinical Implications and Current Treatment Options If you or someone you know has RLS and is struggling emotionally, it is worth raising directly with a healthcare provider rather than assuming better sleep will fix everything.
Non-Drug Approaches That Have Evidence Behind Them
Several non-pharmacological strategies have been tested in randomized trials. A systematic review of these interventions found that exercise, compression devices, certain types of acupuncture, and repetitive transcranial magnetic stimulation all outperformed control conditions in reducing RLS severity. On the other hand, vibration pads, cryotherapy, and transcranial direct current stimulation did not show clear benefits for symptom severity, though some of these did improve sleep quality measures.25PubMed. Non-pharmacological interventions for restless legs syndrome: a systematic review of randomised controlled trials
A more recent meta-analysis found that vibration and electrical stimulation devices produced a significant reduction in symptom severity, while the evidence for massage, cryotherapy, and exercise was less consistent. Sleep quality, measured by standardized questionnaires, improved across the board with non-drug interventions as a group.26PubMed Central. Effect of Vibration, Electrical Stimulation and Other Non-Pharmacological Interventions on Restless Leg Syndrome Severity and Sleep Quality: A Systematic Review and Meta-Analysis Among hemodialysis patients specifically, an eight-week stretching exercise program significantly reduced RLS severity compared to a control group.27PubMed Central. The Effect of Stretching Exercises on Severity of Restless Legs Syndrome in Patients on Hemodialysis
Practical takeaways from this evidence: regular leg stretching and moderate exercise are low-risk and have the most consistent support. Compression garments and pneumatic devices are worth trying. Hot or cold therapy and massage may improve sleep even if they do not reliably reduce the RLS sensations themselves. These approaches work best as complements to other treatment, not necessarily as replacements for medication in moderate-to-severe cases.
Iron Supplementation
Because brain iron deficiency is central to RLS in many patients, correcting iron levels is often the first medical step. An international task force guideline concluded that intravenous ferric carboxymaltose (a single high-dose infusion) is effective for moderate-to-severe RLS in people whose serum ferritin is below 300 micrograms per liter and can be used as a first-line treatment. Oral iron supplements are possibly effective for those with serum ferritin at or below 75 micrograms per liter.28PubMed. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report A pilot randomized trial comparing intravenous and oral iron in people with iron-deficiency anemia and RLS found both routes produced marked symptom improvement, with no significant difference between them.29PubMed. A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia
The important nuance here is the ferritin threshold. Many clinicians consider a ferritin above 20 or 30 “normal” for general health purposes, but in RLS treatment, most specialists aim for ferritin above 75, and ideally above 100, before concluding that iron supplementation is not going to help. If your ferritin was checked and deemed “fine” at 40, it may be worth revisiting.
Prescription Medications and the Augmentation Trap
When iron correction and non-drug strategies are not enough, two main medication classes are used: alpha-2-delta ligands (gabapentin enacarbil and pregabalin) and dopamine agonists (like pramipexole, ropinirole, and rotigotine patches). A comparative meta-analysis of 35 trials found that gabapentin enacarbil, pregabalin, and rotigotine were all similarly effective and all superior to placebo, with no significant differences among them.30PubMed. Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis
The choice between these classes, however, is not a coin flip. A head-to-head trial comparing pregabalin with pramipexole found that pregabalin produced a greater reduction in symptom scores, and about 71 percent of people on pregabalin rated themselves much or very much improved, compared to about 47 percent on placebo. More critically, the rate of augmentation over a year was significantly lower with pregabalin than with the higher dose of pramipexole.31PubMed. Comparison of pregabalin with pramipexole for restless legs syndrome
Augmentation is the most important complication to understand if you are taking or considering dopamine-based treatment for RLS. It means the medication itself causes your symptoms to become worse than they were before you started treatment. Symptoms start appearing earlier in the day, spread to the arms, feel more intense, and the drug seems to require ever-increasing doses to keep working.32The Open Neurology Journal. Augmentation in Restless Legs Syndrome: Treatment with Gradual Medication Modification The underlying mechanism likely involves dopamine agonists driving dopamine receptor desensitization and disrupting the brain’s natural dopamine regulation.33PubMed Central. Exploring the causes of augmentation in restless legs syndrome This is why many RLS specialists now favor alpha-2-delta ligands as the first prescription choice and reserve dopamine agonists for cases that do not respond, or use them at the lowest effective dose.
RLS in Children
RLS is not just an adult condition, but it is routinely missed in children. Kids often cannot articulate the distinctive RLS sensations in ways that map neatly to the adult diagnostic criteria, and their restlessness may be attributed to behavioral issues or growing pains. In a small but revealing study, 10 out of 11 children who had been diagnosed with “growing pains” actually met the clinical criteria for RLS, and six of those ten also had attention-deficit/hyperactivity disorder (ADHD).34PubMed. Some children with growing pains may actually have restless legs syndrome
A systematic review confirmed that pediatric RLS is comorbid with a number of both physical and neuropsychiatric conditions, and its atypical presentation in children contributes to underdiagnosis.35PubMed. Somatic and neuropsychiatric comorbidities in pediatric restless legs syndrome: A systematic review of the literature If a child complains of vague leg discomfort that reliably happens at bedtime, struggles to fall asleep, and has a family history of RLS, a conversation with a pediatric neurologist or sleep specialist can be worthwhile. Treatment in children typically begins with iron assessment, since iron deficiency is common in growing kids and is one of the most treatable contributors.
A Condition That Took Centuries to Be Taken Seriously
The symptoms now called restless legs syndrome were first described in print by the English physician Thomas Willis in 1685. For the next 260 years, the condition appeared only sporadically in medical literature and was mostly regarded as a curiosity. It was not until Swedish neurologist Karl-Axel Ekbom published a detailed clinical description in 1944 that RLS began to be treated as a legitimate medical entity.36PubMed. Restless legs syndrome: an historical note37PubMed Central. Restless legs syndrome: Over 50 years of European contribution Even after Ekbom’s work, skepticism persisted for decades. The condition’s subjective symptoms, lack of visible pathology, and circadian pattern made it easy for clinicians to dismiss. That long history of being ignored may explain why many people today still hesitate to mention their symptoms, or why some physicians still treat RLS as a minor nuisance rather than the neurological disorder it is. If your legs will not let you rest, the science says you are not imagining things.